SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-006266
Filing Date
2023-03-06
Accepted
2023-03-06 16:32:12
Documents
56
Period of Report
2023-03-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dawn-20230306.htm   iXBRL 8-K 65849
2 EX-99.1 dawn-ex99_1.htm EX-99 173043
3 EX-99.2 dawn-ex99_2.htm EX-99 50702
4 GRAPHIC img109617361_0.jpg GRAPHIC 20511
5 GRAPHIC dawn-ex99_2s1.jpg GRAPHIC 137225
6 GRAPHIC dawn-ex99_2s2.jpg GRAPHIC 768970
7 GRAPHIC dawn-ex99_2s3.jpg GRAPHIC 388197
8 GRAPHIC dawn-ex99_2s4.jpg GRAPHIC 420592
9 GRAPHIC dawn-ex99_2s5.jpg GRAPHIC 354639
10 GRAPHIC dawn-ex99_2s6.jpg GRAPHIC 123559
11 GRAPHIC dawn-ex99_2s7.jpg GRAPHIC 463255
12 GRAPHIC dawn-ex99_2s8.jpg GRAPHIC 410636
13 GRAPHIC dawn-ex99_2s9.jpg GRAPHIC 386326
14 GRAPHIC dawn-ex99_2s10.jpg GRAPHIC 402234
15 GRAPHIC dawn-ex99_2s11.jpg GRAPHIC 275986
16 GRAPHIC dawn-ex99_2s12.jpg GRAPHIC 418340
17 GRAPHIC dawn-ex99_2s13.jpg GRAPHIC 286619
18 GRAPHIC dawn-ex99_2s14.jpg GRAPHIC 141039
19 GRAPHIC dawn-ex99_2s15.jpg GRAPHIC 453258
20 GRAPHIC dawn-ex99_2s16.jpg GRAPHIC 357265
21 GRAPHIC dawn-ex99_2s17.jpg GRAPHIC 377750
22 GRAPHIC dawn-ex99_2s18.jpg GRAPHIC 465377
23 GRAPHIC dawn-ex99_2s19.jpg GRAPHIC 340483
24 GRAPHIC dawn-ex99_2s20.jpg GRAPHIC 384999
25 GRAPHIC dawn-ex99_2s21.jpg GRAPHIC 334958
26 GRAPHIC dawn-ex99_2s22.jpg GRAPHIC 112329
27 GRAPHIC dawn-ex99_2s23.jpg GRAPHIC 412845
28 GRAPHIC dawn-ex99_2s24.jpg GRAPHIC 448079
29 GRAPHIC dawn-ex99_2s25.jpg GRAPHIC 400200
30 GRAPHIC dawn-ex99_2s26.jpg GRAPHIC 100912
31 GRAPHIC dawn-ex99_2s27.jpg GRAPHIC 321079
32 GRAPHIC dawn-ex99_2s28.jpg GRAPHIC 328063
33 GRAPHIC dawn-ex99_2s29.jpg GRAPHIC 263391
34 GRAPHIC dawn-ex99_2s30.jpg GRAPHIC 296629
35 GRAPHIC dawn-ex99_2s31.jpg GRAPHIC 320930
36 GRAPHIC dawn-ex99_2s32.jpg GRAPHIC 385516
37 GRAPHIC dawn-ex99_2s33.jpg GRAPHIC 318937
38 GRAPHIC dawn-ex99_2s34.jpg GRAPHIC 352052
39 GRAPHIC dawn-ex99_2s35.jpg GRAPHIC 523299
40 GRAPHIC dawn-ex99_2s36.jpg GRAPHIC 354533
41 GRAPHIC dawn-ex99_2s37.jpg GRAPHIC 416154
42 GRAPHIC dawn-ex99_2s38.jpg GRAPHIC 377786
43 GRAPHIC dawn-ex99_2s39.jpg GRAPHIC 293630
44 GRAPHIC dawn-ex99_2s40.jpg GRAPHIC 298013
45 GRAPHIC dawn-ex99_2s41.jpg GRAPHIC 438278
  Complete submission text file 0000950170-23-006266.txt   20371806

Data Files

Seq Description Document Type Size
46 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dawn-20230306.xsd EX-101.SCH 2472
47 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dawn-20230306_lab.xml EX-101.LAB 13350
48 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dawn-20230306_pre.xml EX-101.PRE 9842
50 EXTRACTED XBRL INSTANCE DOCUMENT dawn-20230306_htm.xml XML 4730
Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Filer) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40431 | Film No.: 23709355
SIC: 2834 Pharmaceutical Preparations